AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements

Overview of attention for article published in The Journal of Experimental Medicine, November 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 12 patents

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 12 patents that reference this research output.

Methods of using RAD51 inhibitors for treatment of pancreatic cancer

Grant US-12064419-B2

United States of America

20 Aug 2024

RAD51 inhibitors

Grant US-11932636-B2

United States of America

19 Mar 2024

Combinations of RAD51 and PARP inhibitors

Grant US-11607404-B2

United States of America

21 Mar 2023

RAD51 INHIBITORS

Application EP-4112616-A1

European Patent Office

04 Jan 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.